HomeAI · summaries
Storia in 3 fonti
GLP-1 Receptor Agonists Slow Epigenetic Aging, a Measure of the Harms Done by Excess Visceral Fat
Weight loss drugs are a major focus of the pharmaceutical industry at present. It remains to be seen as to what will emerge as the next big class of weight loss drugs following GLP-1 receptor agonists. Since the primary effect of GLP-1 receptor agonist drugs is a reduction in calorie intake, all of the gathered...
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
Weight loss drugs show signs of slowing biological aging, scientists discover
GLP-1 drugs help fight the harmful inflammation that raises the risk of chronic disease
- ·
forbes.com
GLP-1 Drugs May Protect Against Cancer— Here’s What That Means For Public Health
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
